Monocyte-derived macrophages, the major source of pathogenic macrophages in COVID-19, are oppositely instructed by macrophage CSF (M-CSF) or granulocyte macrophage CSF (GM-CSF), which promote the ...generation of antiinflammatory/immunosuppressive MAFB+ (M-MØ) or proinflammatory macrophages (GM-MØ), respectively. The transcriptional profile of prevailing macrophage subsets in severe COVID-19 led us to hypothesize that MAFB shapes the transcriptome of pulmonary macrophages driving severe COVID-19 pathogenesis. We have now assessed the role of MAFB in the response of monocyte-derived macrophages to SARS-CoV-2 through genetic and pharmacological approaches, and we demonstrate that MAFB regulated the expression of the genes that define pulmonary pathogenic macrophages in severe COVID-19. Indeed, SARS-CoV-2 potentiated the expression of MAFB and MAFB-regulated genes in M-MØ and GM-MØ, where MAFB upregulated the expression of profibrotic and neutrophil-attracting factors. Thus, MAFB determines the transcriptome and functions of the monocyte-derived macrophage subsets that underlie pulmonary pathogenesis in severe COVID-19 and controls the expression of potentially useful biomarkers for COVID-19 severity.
By the end of December 2021, coronavirus disease 2019 (COVID-19) produced more than 271 million cases and 5.3 million deaths. Although vaccination is an effective strategy for pandemic control, it is ...not yet equally available in all countries. Therefore, identification of prognostic biomarkers remains crucial to manage COVID-19 patients. The aim of this study was to evaluate predictors of COVID-19 severity previously proposed. Clinical and demographic characteristics and 120 single-nucleotide polymorphisms were analyzed from 817 patients with COVID-19, who attended the emergency department of the Hospital Universitario de La Princesa during March and April 2020. The main outcome was a modified version of the 7-point World Health Organization (WHO) COVID-19 severity scale (WHOCS); both in the moment of the first hospital examination (WHOCS-1) and of the severest WHOCS score (WHOCS-2). The
rs75603675 genotype (OR = 0.586), dyslipidemia (OR = 2.289), sex (OR = 0.586), and the Charlson Comorbidity Index (OR = 1.126) were identified as the main predictors of disease severity. Consequently, these variables might influence COVID-19 severity and could be used as predictors of disease development.
We identified an error in the abstract of the article:
rs75603675 OR is incorrectly indicated. It should read (OR = 2.140) instead of (OR = 0.586). We apologize for this error. However, since the ...main text is correct, it has no impact on the results displayed in the study.
Introduction
SARS-CoV-2 viral load has been related to COVID-19 severity. The main aim of this study was to evaluate the relationship between SARS-CoV-2 viremia and SNPs in genes previously studied ...by our group as predictors of COVID-19 severity.
Materials and methods
Retrospective observational study including 340 patients hospitalized for COVID-19 in the University Hospital La Princesa between March 2020 and December 2021, with at least one viremia determination. Positive viremia was considered when viral load was above the quantifiable threshold (20 copies/ml). A total of 38 SNPs were genotyped. To study their association with viremia a multivariate logistic regression was performed.
Results
The mean age of the studied population was 64.5 years (SD 16.6), 60.9% patients were male and 79.4% white non-Hispanic. Only 126 patients (37.1%) had at least one positive viremia. After adjustment by confounders, the presence of the minor alleles of rs2071746 (
HMOX1
; T/T genotype OR 9.9
p
< 0.0001), rs78958998 (probably associated with
SERPING1
expression; A/T genotype OR 2.3,
p
= 0.04 and T/T genotype OR 12.9,
p
< 0.0001), and rs713400 (eQTL for
TMPRSS2
; C/T + T/T genotype OR 1.86,
p
= 0.10) were associated with higher risk of viremia, whereas the minor alleles of rs11052877 (
CD69
; A/G genotype OR 0.5, p = 0.04 and G/G genotype OR 0.3,
p
= 0.01), rs2660 (
OAS1
; A/G genotype OR 0.6,
p
= 0.08), rs896 (
VIPR1
; T/T genotype OR 0.4,
p
= 0.02) and rs33980500 (
TRAF3IP2
; C/T + T/T genotype OR 0.3,
p
= 0.01) were associated with lower risk of viremia.
Conclusion
Genetic variants in
HMOX1
(rs2071746),
SERPING1
(rs78958998),
TMPRSS2
(rs713400),
CD69
(rs11052877),
TRAF3IP2
(rs33980500),
OAS1
(rs2660) and
VIPR1
(rs896) could explain heterogeneity in SARS-CoV-2 viremia in our population.
